MEIS3
Homeobox protein Meis3
Also known as: DKFZp547H236, MEIS3_HUMAN, MRG2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99687
- Gene
- MEIS3
- Ensembl
- ENSG00000105419
- Chromosome
- 19
- Canonical length
- 375 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a homeobox protein and probable transcriptional regulator. The orthologous protein in mouse controls expression of 3-phosphoinositide dependent protein kinase 1, which promotes survival of pancreatic beta-cells. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>Q99687|MEIS3
1 MARRYDELPH YPGIVDGPAA LASFPETVPA VPGPYGPHRP PQPLPPGLDS DGLKREKDEI
61 YGHPLFPLLA LVFEKCELAT CSPRDGAGAG LGTPPGGDVC SSDSFNEDIA AFAKQVRSER
121 PLFSSNPELD NLMIQAIQVL RFHLLELEKV HDLCDNFCHR YITCLKGKMP IDLVIEDRDG
181 GCREDFEDYP ASCPSLPDQN NMWIRDHEDS GSVHLGTPGP SSGGLASQSG DNSSDQGDGL
241 DTSVASPSSG GEDEDLDQER RRNKKRGIFP KVATNIMRAW LFQHLSHPYP SEEQKKQLAQ
301 DTGLTILQVN NWFINARRRI VQPMIDQSNR TGQGAAFSPE GQPIGGYTET QPHVAVRPPG
361 SVGMSLNLEG EWHYLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MEIS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 115 nTPM
- cerebral cortex: 108 nTPM
- hippocampal formation: 87 nTPM
- endometrium: 80 nTPM
- fallopian tube: 62 nTPM
- cervix: 41 nTPM
Single-cell type
- late spermatids: 102 nCPM
- early spermatids: 81 nCPM
- retinal amacrine cells: 62 nCPM
- smooth muscle cells: 59 nCPM
- brain excitatory neurons: 58 nCPM
- other brain neurons: 44 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 132 nTPM
- amygdala: 124 nTPM
- hippocampal formation: 121 nTPM
- basal ganglia: 107 nTPM
- hypothalamus: 86 nTPM
- white matter: 75 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- animal organ morphogenesis
- brain development
- embryonic pattern specification
- eye development
- hemopoiesis
- positive regulation of cell population proliferation
- positive regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MEIS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MEIS3 as an antibody target. Whether an autoantibody or antibody against MEIS3 could matter depends on whether native MEIS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MEIS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MEIS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...